Base-case sensitivity analysis
| Variables . | Prophylaxis . | Gene therapy . | Difference . |
|---|---|---|---|
| Total cost | $1 693 630 | $1 022 249 | $671 381 |
| Effectiveness, QALYs | 6.62 | 8.33 | −1.71 |
| Incremental cost-effectiveness ratio, $/QALY | Dominated | Dominant |
| Variables . | Prophylaxis . | Gene therapy . | Difference . |
|---|---|---|---|
| Total cost | $1 693 630 | $1 022 249 | $671 381 |
| Effectiveness, QALYs | 6.62 | 8.33 | −1.71 |
| Incremental cost-effectiveness ratio, $/QALY | Dominated | Dominant |
Cost and QALYs are discounted at 3% per year.